-
Loading metrics
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
- Idoia Busnadiego,
- Irene A. Abela,
- Pascal M. Frey,
- Daniel A. Hofmaenner,
- Thomas C. Scheier,
- Reto A. Schuepbach,
- Philipp K. Buehler,
- Silvio D. Brugger,
- Benjamin G. Hale
x
-
- Published: July 5, 2022
- https://doi.org/10.1371/journal.pbio.3001709